<DOC>
	<DOCNO>NCT00003686</DOCNO>
	<brief_summary>RATIONALE : Pilocarpine may help relieve dry mouth patient receive opioids cancer therapy . It yet know whether pilocarpine effective treatment condition . PURPOSE : Randomized phase III trial determine effectiveness pilocarpine treat patient dry mouth cause opioids .</brief_summary>
	<brief_title>Pilocarpine Treating Patients With Dry Mouth Caused Opioids</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate effectiveness daily oral pilocarpine versus placebo relieve dry mouth due ongoing use opioid cancer relate pain 2 week compare proportion patient least one response 2 week period , time first response , duration first response . II . Evaluate adverse effect pilocarpine patient . III . Evaluate whether constipation , sedation , poor appetite , nausea ameliorate pilocarpine patient . IV . Evaluate effect pilocarpine quality life patient group . V. Determine time duration effect pilocarpine patient population . OUTLINE : This randomize , double-blind , multicenter study . Patients receive either oral pilocarpine four time daily ( arm I ) oral placebo four time daily ( arm II ) 4 week . At end 4 week , patient give option receive oral pilocarpine . Quality life assess 2 day prior randomization , 2 week treatment , 4 week treatment . PROJECTED ACCRUAL : There 60 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Pilocarpine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Complaint dry mouth ALL follow characteristic : At least 1 week duration Attributed treat physician opioid Severity rating least 20 mm 100 mm visual analog scale Must receive routine ( i.e. , need ) dose one follow opioids : morphine , hydromorphone , transdermal fentanyl , methadone , oxycodone Intent continue opioid therapy high dose first 2 week patient receive protocol treatment PATIENT CHARACTERISTICS : Age : 16 Performance status : ECOG 03 Life expectancy : At least 6 week Hematopoietic : Not specify Hepatic : Not specify Renal : Calcium le 29.9 mg/dL Cardiovascular : No symptomatic congestive heart failure hypotension ( systolic blood pressure le 100 mm Hg ) Pulmonary : No obstructive pulmonary disease ( asthma , chronic bronchitis , chronic obstructive pulmonary disease ) Other : No known sensitivity pilocarpine No active oral candidiasis No Sjogren 's syndrome No acute iritis narrowangle glaucoma Not pregnant nursing Effective contraception require fertile patient Must fluent posse sufficient cognitive ability complete quality life questionnaires either English French without assistance caregiver PRIOR CONCURRENT THERAPY : See Disease Characteristics Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy field encompass parotid gland At least 1 week since prior radiotherapy chief site pain No concurrent radiotherapy chief site pain 2 week follow randomization Surgery : Not specify Other : No concurrent tricyclic antidepressant ( amitriptyline , nortriptyline , desipramine , imipramine )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>oral complication</keyword>
	<keyword>quality life</keyword>
</DOC>